The rationale for neoadjuvant radiation therapy in malignant pleural mesothelioma: how smart is SMART?

ανά Cho, B. C. John
Τόπος έκδοσης Ann Transl Med (2017)

Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

ανά Westover, D, Zugazagoitia, J, Cho, B C, Lovly, C M, Paz-Ares, L
Τόπος έκδοσης Ann Oncol (2018)

Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer

ανά Yung, T., Giuliani, M.E., Le, L.W., Sun, A., Cho, B.C.J., Bezjak, A., Brade, A., Hope, A.J.
Έκδοση 2012

Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.

ανά Cho, B C, Shaughnessy, J D, Largaespada, D A, Bedigian, H G, Buchberg, A M, Jenkins, N A, Copeland, N G
Έκδοση 1995

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens

ανά Jeung, H-C, Rha, S Y, Cho, B C, Yoo, N C, Roh, J K, Roh, W J, Chung, H C, Ahn, J B
Έκδοση 2006

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy

ανά Giuliani, M., Sampson, L.R., Wong, O., Gay, J., Le, L.W., Cho, B.C.J., Brade, A., Sun, A., Bezjak, A., Hope, A.J.
Τόπος έκδοσης Curr Oncol (2016)

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

ανά Kim, S-M, Kim, H, Yun, M R, Kang, H N, Pyo, K-H, Park, H J, Lee, J M, Choi, H M, Ellinghaus, P, Ocker, M, Paik, S, Kim, H R, Cho, B C
Τόπος έκδοσης Oncogenesis (2016)

Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy

ανά Tagawa, Tetsuzo, Anraku, Masaki, Morodomi, Yosuke, Takenaka, Tomoyoshi, Okamoto, Tatsuro, Takenoyama, Mitsuhiro, Ichinose, Yukito, Maehara, Yoshihiko, Cho, B. C. John, Feld, Ronald, Tsao, Ming-Sound, Leighl, Natasha, Bezjak, Andrea, Keshavjee, Shaf, de Perrot, Marc
Τόπος έκδοσης J Thorac Dis (2015)

Dabrafenib in BRAF V600E–Mutant Advanced Non-Small Cell Lung Cancer: an Open-label, Single arm, Multicenter, Phase 2 Trial

ανά Planchard, David, Kim, Tae Min, Mazieres, Julien, Quoix, Elisabeth, Riely, Gregory, Barlesi, Fabrice, Souquet, Pierre-John, Smit, Egbert F., Groen, Harry J. M., Kelly, Ronan J., Cho, B. C., Socinski, Mark A., Pandite, Lini, Nase, Christine, Ma, Bo, D’Amelio, Anthony, Mookerjee, Bijoyesh, Curtis, C. Martin, Johnson, Bruce E.
Τόπος έκδοσης Lancet Oncol (2016)

A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis

ανά Yan, Michael, Sigurdson, Samantha, Greifer, Noah, Kennedy, Thomas A. C., Toh, Tzen S., Lindsay, Patricia E., Weiss, Jessica, Hueniken, Katrina, Yeung, Christy, Sugumar, Vijithan, Sun, Alexander, Bezjak, Andrea, Cho, B. C. John, Raman, Srinivas, Hope, Andrew J., Giuliani, Meredith E., Stuart, Elizabeth A., Owen, Timothy, Ashworth, Allison, Robinson, Andrew, de Moraes, Fabio Ynoe, Liu, Geoffrey, Lok, Benjamin H.
Τόπος έκδοσης Cancers (Basel) (2021)